BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Annalora AJ, Marcus CB, Iversen PL. Alternative Splicing in the Nuclear Receptor Superfamily Expands Gene Function to Refine Endo-Xenobiotic Metabolism. Drug Metab Dispos 2020;48:272-87. [DOI: 10.1124/dmd.119.089102] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Fan X, Zhang Y, Qiu L, Zhu W, Tu X, Miao Y. Identification and characterization of alternative splicing variants of buffalo LXRα expressed in mammary gland. Sci Rep 2022;12:10588. [PMID: 35732883 DOI: 10.1038/s41598-022-14771-0] [Reference Citation Analysis]
2 Thorne JL, Cioccoloni G. Nuclear Receptors and Lipid Sensing. Advances in Experimental Medicine and Biology 2022. [DOI: 10.1007/978-3-031-11836-4_5] [Reference Citation Analysis]
3 Lianto P, Hutchinson SA, Moore JB, Hughes TA, Thorne JL. Characterization and prognostic value of LXR splice variants in triple-negative breast cancer. iScience 2021;24:103212. [PMID: 34755086 DOI: 10.1016/j.isci.2021.103212] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Lianto P, Moore JB, Hughes TA, Thorne JL. Comprehensive profiling of liver x receptor splicing in triple negative breast cancer reveals existence of novel splice variants that are prognostic for survival.. [DOI: 10.1101/2021.06.09.445161] [Reference Citation Analysis]
5 Mustonen EK, Lee SML, Nieß H, Schwab M, Pantsar T, Burk O. Identification and characterization of novel splice variants of human farnesoid X receptor. Arch Biochem Biophys 2021;705:108893. [PMID: 33930378 DOI: 10.1016/j.abb.2021.108893] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Alatshan A, Benkő S. Nuclear Receptors as Multiple Regulators of NLRP3 Inflammasome Function. Front Immunol 2021;12:630569. [PMID: 33717162 DOI: 10.3389/fimmu.2021.630569] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
7 Lianto P, Hughes T, Moore B, Thorne L. Splicing of the cholesterol homeostasis protein LXR is a prognostic indicator for triple negative breast cancer patients. Proc Nutr Soc 2020;79:E757. [DOI: 10.1017/s0029665120007430] [Reference Citation Analysis]